Literature DB >> 3053245

Cloning a synthetic gene for human stefin B and its expression in E. coli.

R Jerala1, M Trstenjak, B Lenarcic, V Turk.   

Abstract

A gene coding for human stefin B was synthesized by the solid-phase phosphite method and cloned in the pUC8 cloning vector. The insert with the verified DNA sequence was subcloned into two expression vectors and expressed in E. coli as a fusion protein with beta-galactosidase and as a native protein. The CNBr cleaved fusion protein and the native recombinant stefin B were inhibitory to papain and reacted with antibodies against human stefin B.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053245     DOI: 10.1016/0014-5793(88)80541-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Differences in aggregation properties of three site-specific mutants of recombinant human stefin B.

Authors:  Manca Kenig; Selma Berbić; Aida Krijestorac; Louise Kroon-Zitko; Magda Tusek; Marusa Pompe-Novak; Eva Zerovnik
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

2.  In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.

Authors:  Sabina Rabzelj; Vito Turk; Eva Zerovnik
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

3.  Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells.

Authors:  Katja Skerget; Ajda Taler-Vercic; Andrej Bavdek; Vesna Hodnik; Slavko Ceru; Magda Tusek-Znidaric; Tiina Kumm; Didier Pitsi; Marusa Pompe-Novak; Peep Palumaa; Salvador Soriano; Natasa Kopitar-Jerala; Vito Turk; Gregor Anderluh; Eva Zerovnik
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

4.  Modulation of contact order effects in the two-state folding of stefins A and B.

Authors:  Clare Jelinska; Peter J Davis; Manca Kenig; Eva Zerovnik; Saša Jenko Kokalj; Gregor Gunčar; Dušan Turk; Vito Turk; David T Clarke; Jonathan P Waltho; Rosemary A Staniforth
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

Review 5.  Molecular background of progressive myoclonus epilepsy.

Authors:  Anna-Elina Lehesjoki
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

6.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

7.  The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.

Authors:  M T Stubbs; B Laber; W Bode; R Huber; R Jerala; B Lenarcic; V Turk
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

8.  Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB.

Authors:  Véronique Brault; Benoît Martin; Nathalie Costet; Jean-Charles Bizot; Yann Hérault
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

9.  The role of initial oligomers in amyloid fibril formation by human stefin B.

Authors:  Ajda Taler-Verčič; Tiina Kirsipuu; Merlin Friedemann; Andra Noormägi; Mira Polajnar; Julia Smirnova; Magda Tušek Znidarič; Matjaž Zganec; Miha Skarabot; Andrej Vilfan; Rosemary A Staniforth; Peep Palumaa; Eva Zerovnik
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

10.  Proline Residues as Switches in Conformational Changes Leading to Amyloid Fibril Formation.

Authors:  Ajda Taler-Verčič; Samra Hasanbašić; Selma Berbić; Veronika Stoka; Dušan Turk; Eva Žerovnik
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.